Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study
-
Published:2020-07-20
Issue:1
Volume:13
Page:
-
ISSN:1756-8722
-
Container-title:Journal of Hematology & Oncology
-
language:en
-
Short-container-title:J Hematol Oncol
Author:
Deng Yujiao, Zhao Peng, Zhou Linghui, Xiang Dong, Hu Jingjing, Liu Yu, Ruan Jian, Ye Xianghua, Zheng Yi, Yao Jia, Zhai Zhen, Wang Shuqian, Yang Si, Wu Ying, Li Na, Xu Peng, Zhang Dai, Kang Huafeng, Lyu Jun, Dai ZhijunORCID
Abstract
Abstract
Background
Investigations of disease incidence, mortality, and disability-adjusted life years (DALYs) are valuable for facilitating preventive measures and health resource planning. We examined the tracheal, bronchus, and lung (TBL) cancer burdens worldwide according to sex, age, and social development index (SDI) at the global, regional, and national levels.
Methods
We assessed the TBL cancer burden using data from the Global Burden of Disease (GBD) database, including 21 regions, 195 countries, and territories in the diagnostic period 1990–2017. The data of TBL cancer-related mortality and DALYs attributable to all known risk factors were also analyzed. Age-standardized rates (ASRs) and their estimated annual percentage changes (EAPCs) were calculated.
Results
Incident cases, deaths, and DALYs of TBL cancer increased worldwide (100.44%, 82.30%, and 61.27%, respectively). The age-standardized incidence rate (ASIR) was stable (EAPC = 0.02, 95% confidence interval [CI] − 0.03 to 0.08), but the age-standardized death (EAPC = − 0.34, 95%CI − 0.38 to − 0.3) and DALY rate decreased generally (EAPC = − 0.74, 95%CI − 0.8 to − 0.68). However, the change trend of ASIR and ASDR among sexes was on the contrary. China and the USA always had the highest incidence, mortality, and DALYs of TBL cancer. Significant positive correlations between ASRs and SDI were observed, especially among females. High (36.86%), high-middle (28.78%), and middle SDI quintiles (24.91%) carried the majority burden of TBL cancer. Tobacco remained the top cause of TBL cancer death and DALYs, followed by air pollution, the leading cause in the low-middle and low-SDI quintiles. Metabolic risk-related TBL cancer mortality and DALYs among females increased but was stable among males. The main ages of TBL cancer onset and death were > 50 years, and the DALYs concentrated in 50 − 69 years.
Conclusions
To significantly reduce the growing burden of TBL cancer, treatment resources need to be skewed according to factors such as risks and geography, especially for high-risk groups and high-burden areas. Asia had the greatest TBL cancer burden, followed by high-income North America. Tobacco remains the leading cause of death and DALYs, followed by air pollution. Effective prevention measures against tobacco and air pollution should be strengthened.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Biology,Hematology
Reference50 articles.
1. McKay JD, Hung RJ, Han Y, Zong X, Carreras-Torres R, Christiani DC, et al. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet. 2017;49(7):1126–32. 2. Lorenzo-Gonzalez M, Ruano-Ravina A, Torres-Duran M, Provencio-Pulla M, Kelsey K, Parente-Lamelas I, et al. Lung cancer risk and do-it-yourself activities. A neglected risk factor for lung cancer. Environ Res. 2019;179(Pt B):108812. 3. Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, et al. Lung cancer: current therapies and new targeted treatments. Lancet (London, England). 2017;389(10066):299–311. 4. Jemal A, Miller KD, Ma J, Siegel RL, Fedewa SA, Islami F, et al. Higher lung cancer incidence in young women than young men in the United States. N Engl J Med. 2018;378(21):1999–2009. 5. Barnett R. Lung cancer. Lancet (London, England). 2017;390(10098):928.
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery of a potent, selective, and orally available EGFR C797S mutant inhibitor (DS06652923) with in vivo antitumor activity;Bioorganic & Medicinal Chemistry;2024-09 2. Global, regional, and national burden of trachea, bronchus, and lung cancer among women of reproductive age, 1990–2019;Cancer Epidemiology;2024-08 3. Global, regional, and national cancer burdens of respiratory and digestive tracts in 1990–2044: A cross-sectional and age-period-cohort forecast study;Cancer Epidemiology;2024-08 4. Correlation of time trends of air pollutants, greenspaces and tracheal, bronchus and lung cancer incidence and mortality among the adults in United States;Frontiers in Oncology;2024-07-25 5. Time Trends and Geographic Patterns of Mortality Due to Tracheal, Bronchus, and Lung Cancer in Portugal;Applied Sciences;2024-07-08
|
|